BCL9L

BCL9L
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	2XB1, 4UP0, 4UP5
Identifiers
Aliases	BCL9L, BCL9-2, DLNB11, B-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9 like, B cell CLL/lymphoma 9 like
External IDs	MGI: 1933114 HomoloGene: 65615 GeneCards: BCL9L
Gene location (Human)
Chr.	Chromosome 11 (human)[1]
End	118,925,608 bp[1]
Gene location (Mouse)
Chr.	Chromosome 9 (mouse)[2]
End	44,511,896 bp[2]
Gene ontology
Molecular function	• transcription coactivator activity; • beta-catenin binding;
Cellular component	• nucleolus; • cell nucleus; • nucleoplasm; • beta-catenin-TCF complex;
Biological process	• regulation of cell morphogenesis; • regulation of transcription, DNA-templated; • negative regulation of transforming growth factor beta receptor signaling pathway; • positive regulation of epithelial to mesenchymal transition; • transcription, DNA-templated; • beta-catenin-TCF complex assembly; • canonical Wnt signaling pathway; • somatic stem cell population maintenance; • skeletal muscle cell differentiation; • positive regulation of transcription from RNA polymerase II promoter;
	Sources:Amigo / QuickGO
Orthologs
	283149
	80288
	ENSG00000186174
	ENSMUSG00000063382
	Q86UU0
	Q67FY2
	NM_182557
	NM_030256; NM_001357490
	NP_872363
	NP_084532; NP_001344419
	Wikidata
View/Edit Human	View/Edit Mouse

B-cell CLL/lymphoma 9 like is a protein that in humans is encoded by the BCL9L gene. ^[5]

References

1 2 3 GRCh38: Ensembl release 89: ENSG00000186174 - Ensembl, May 2017
1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000063382 - Ensembl, May 2017
↑ "Human PubMed Reference:".
↑ "Mouse PubMed Reference:".
↑ "Entrez Gene: B-cell CLL/lymphoma 9 like". Retrieved 2017-10-31.

Sampietro J, Dahlberg CL, Cho US, Hinds TR, Kimelman D, Xu W (2006). "Crystal structure of a beta-catenin/BCL9/Tcf4 complex". Mol. Cell. 24 (2): 293–300. doi:10.1016/j.molcel.2006.09.001. PMID 17052462.
Miller TC, Rutherford TJ, Johnson CM, Fiedler M, Bienz M (2010). "Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor". J. Mol. Biol. 401 (5): 969–84. doi:10.1016/j.jmb.2010.07.007. PMC 2927781. PMID 20637214.
Brembeck FH, Wiese M, Zatula N, Grigoryan T, Dai Y, Fritzmann J, Birchmeier W (2011). "BCL9-2 promotes early stages of intestinal tumor progression". Gastroenterology. 141 (4): 1359–70, 1370.e1–3. doi:10.1053/j.gastro.2011.06.039. PMID 21703997.
Matsuura K, Jigami T, Taniue K, Morishita Y, Adachi S, Senda T, Nonaka A, Aburatani H, Nakamura T, Akiyama T (2011). "Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway". Nat Commun. 2: 548. doi:10.1038/ncomms1551. PMID 22109522.
Zatula N, Wiese M, Bunzendahl J, Birchmeier W, Perske C, Bleckmann A, Brembeck FH (2014). "The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis". Oncotarget. 5 (16): 6770–87. doi:10.18632/oncotarget.2252. PMC 4196162. PMID 25149534.
El-Hage P, Petitalot A, Monsoro-Burq AH, Maczkowiak F, Driouch K, Formstecher E, Camonis J, Sabbah M, Bièche I, Lidereau R, Lallemand F (2015). "The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells". Mol. Cancer Res. 13 (5): 902–12. doi:10.1158/1541-7786.MCR-14-0180. PMID 25678599.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] 1 2 3 GRCh38: Ensembl release 89: ENSG00000186174 - Ensembl, May 2017

[refGRCm38Ensembl-2] 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000063382 - Ensembl, May 2017

[3] "Human PubMed Reference:".

[4] "Mouse PubMed Reference:".

[entrez-5] "Entrez Gene: B-cell CLL/lymphoma 9 like". Retrieved 2017-10-31.

BCL9L

References

Further reading